Niels van Royen

Showing 1-16 of 16 articles

A randomised trial of sheathless versus conventional access for transradial interventions

van der Heijden D, van Leeuwen M, Brinckman S, Madera Cambero M, Aipassa T, Vart P, van Geuns R, van Royen N

March 19, 2021 | 10.4244/EIJ-D-19-00380

From plumbers to vascular restorers: has the Promethean promise of bioresorbable coronary scaffolds yet to be fulfilled?

Escaned J, van Royen N

June 12, 2020 | 10.4244/EIJV16I2A17

Interventions for valvular disease

Incidence and predictors of vascular complications in transaxillary TAVI

van der Wulp K, Thijs I, van Wely M, Loverbos A, Gehlmann H, Verkroost M, Van Garsse L, Kievit P, Vart P, El Messaoudi S, Bosboom D, Morshuis W, van Royen N

February 7, 2020 | 10.4244/EIJ-D-19-00588

Coronary interventions

The impact on radial injury of sheathless versus conventional access for transradial interventions: a randomized trial

van der Heijden D, van Leeuwen M, Brinckman S, Madera Cambero M, Aipassa T, Vart P, van Geuns R, van Royen N

November 5, 2019 | 10.4244/EIJ-D-19-00380

Coronary interventions

Comprehensive physiological evaluation of epicardial and microvascular coronary domains using vascular conductance and zero flow pressure

van der Hoeven NW, de Waard G, Quirós A, de Hoyos A, Broyd C, Nijjer S, van de Hoef T, Petraco R, Driessen R, Mejía-Rentería H, Kikuta Y, Pinto M, van de Ven P, Meuwissen M, Knaapen P, Piek J, Davies J, van Royen N, Escaned J

February 7, 2019 | 10.4244/EIJ-D-18-00021

Coronary interventions

Optical coherence tomography substudy of a prospective multicentre randomised post-market trial to assess the safety and effectiveness of the Firehawk cobalt-chromium coronary stent (rapamycin target-eluting) system for the treatment of atherosclerotic lesions: TARGET All Comers

Baumbach A, Lansky A, Onuma Y, Asano T, Johnson T, Anderson R, Kiemeneij F, Zeng M, van Royen N, Slagboom T, Vlachojannis G, Serruys P, Wijns W

November 20, 2018 | 10.4244/EIJ-D-18-00226

STEMI

One-year clinical outcome of early administration of intravenous beta-blockers in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary reperfusion

Roolvink V, Ottervanger J, Ibáñez B, Dambrink J, Gosselink M, Kedhi E, van Royen N, Lipsic E, Remkes W, Piek J, Fuster V, van't Hof A

August 24, 2018 | 10.4244/EIJ-D-17-00776

Coronary interventions

Bivalirudin infusion to reduce ventricular infarction: the open-label, randomised Bivalirudin Infusion for Ventricular InfArction Limitation (BIVAL) study

van Geuns R, Sideris G, van Royen N, El Mahmoud R, Diletti R, Sollier C, Garot J, Van Der Hoeven N, Cortese B, Ding L, Lechthaler I, Deliargyris E, Anthopoulos P, Drouet L

August 4, 2017 | 10.4244/EIJ-D-17-00307

Coronary interventions

Comparison of a new slender 6 Fr sheath with a standard 5 Fr sheath for transradial coronary angiography and intervention: RAP and BEAT (Radial Artery Patency and Bleeding, Efficacy, Adverse evenT), a randomised multicentre trial

Aminian A, Saito S, Takahashi A, Bernat I, Jobe R, Kajiya T, Gilchrist I, Louvard Y, Kiemeneij F, van Royen N, Yamazaki S, Matsukage T, Rao S

August 4, 2017 | 10.4244/EIJ-D-16-00816

Coronary interventions

Instantaneous wave-free ratio to guide coronary revascularisation: physiological framework, validation and differences from fractional flow reserve

de Waard G, Di Mario C, Lerman A, Serruys P, van Royen N

July 20, 2017 | 10.4244/EIJ-D-16-00456

Coronary interventions

Effects of successful percutaneous coronary intervention of chronic total occlusions on myocardial perfusion and left ventricular function

Stuijfzand W, Biesbroek P, Raijmakers P, Driessen R, Schumacher S, van Diemen P, van den Berg J, Nijveldt R, Lammertsma A, Walsh S, Hanratty C, Spratt J, van Rossum A, Nap A, van Royen N, Knaapen P

June 20, 2017 | 10.4244/EIJ-D-16-01014

Coronary interventions

The long-term effect of transradial coronary catheterisation on upper limb function

van Leeuwen M, van der Heijden D, Hermie J, Lenzen M, Selles R, Ritt M, Kiemeneij F, Zijlstra F, Van Mieghem N, van Royen N

February 20, 2017 | 10.4244/EIJ-D-15-00395

Coronary interventions

Non-invasive assessment of the collateral circulation in the hand: validation of the Nexfin system and relation to clinical outcome after transradial catheterisation

Hollander M, van Leeuwen M, van der Heijden D, Keizer V, van de Ven P, IJsselmuiden S, Van Mieghem N, Amoroso G, Ritt M, Knaapen P, van Royen N

February 20, 2017 | 10.4244/EIJ-D-16-00337

Coronary interventions

Endothelial dysfunction and the occurrence of radial artery spasm during transradial coronary procedures: the ACRA-Spasm study

van der Heijden D, van Leeuwen M, Janssens G, Hermie J, Lenzen M, Ritt M, van de Ven P, Kiemeneij F, van Royen N

November 20, 2016 | 10.4244/EIJV12I10A207

Coronary interventions

Evaluation of myocardial blood flow and coronary flow reserve after implantation of a bioresorbable vascular scaffold versus metal drug-eluting stent: an interim one-month analysis of the VANISH trial

Stuijfzand W, Raijmakers P, Driessen R, Lammertsma A, van Rossum A, Nap A, Appelman Y, Lemkes J, van Leeuwen M, van Royen N, Knaapen P

August 5, 2016 | 10.4244/EIJV12I5A98

Acute haemodynamic effects of accelerated idioventricular rhythm in primary percutaneous coronary intervention

Delewi R, Remmelink M, Meuwissen M, van Royen N, Vis M, Koch K, Henriques J, de Winter R, Thijssen J, Baan Jr J, Piek J

August 30, 2011 | 10.4244/EIJV7I4A76

Latest news

EDITORIAL

A State-of-the Art and Mini Focus on Intracoronary OCT; Thrombectomy for Acute Ischaemic Stroke; and more…

June 11, 2021

NEW

Intracoronary OCT: State of the Art and Future Directions

Ziad A. Ali et al.

June 11, 2021

PCR Companion attending EuroPCR? Activate your free subscription!

May 28, 2021

TRIALS BOOK

Access the full Trials Book 2021

(Thanks to the support of Biotronik)

May 18, 2021

JAA

This Week's JAA's: ABSORB DAPT, OFR in predicting post-PCI FFR and more...

June 8, 2021

NEW

Joint EAPCI/ACVC expert consensus on pVADs

Alaide Chieffo et al.

May 31, 2021

JAA

New JAA's: Impact of HPR on clopidogrel monotherapy and more...